News

A new graphene oxide platform that mimics the interactions between immune cells could stimulate CAR T cells to reproduce, making CAR T-cell therapy more effective.

Researchers from CNIO and the University of Würzburg have developed a technique to study how different populations of multiple myeloma cells respond to treatments. This approach reveals which cell mutations confer resistance.

Natural killer T cells could be used to produce antitumor activity in solid tumors.

The chemotherapy drug 5-fluorouracil has different mechanisms of action in different cancers, a new study has found.

Researchers are employing artificial intelligence to identify risk factors associated with aggressive glioblastoma tumors. the team uncovered sex-specific patterns that could improve prognosis and lead to more personalized treatment.

Engineered E.coli bacteria can move into tumors and indue potent immune responses, acting as a GPS for immunotherapies.

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests. The findings pave are an important step toward approval as a potential diagnostic method for pancreatic cancer.

A multicenter study found that different KRAS mutations in pancreatic ductal adenocarcinoma affect patient survival outcomes. The KRAS-G12D mutation correlates with aggressive cancer.

UCLA researchers developed a non-invasive imaging method using 89Zr-TLX250 to detect clear-cell renal cell carcinoma. This technique demonstrated high sensitivity (85.5%) and specificity (87.0%), effectively identifying cancer in small renal masses.

A new treatment has been proposed for immunotherapy-resistant brain metastases, with a biomarker identified that can predict cases in which it should be used.